Core Scientific Inc [CORZ] stock is trading at $9.31, up 9.40%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CORZ shares have gain 6.28% over the last week, with a monthly amount drifted -13.80%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Core Scientific Inc [NASDAQ: CORZ] stock has seen the most recent analyst activity on January 27, 2025, when Keefe Bruyette initiated its Outperform rating and assigned the stock a price target of $22. Previously, Craig Hallum started tracking the stock with Buy rating on January 21, 2025, and set its price target to $24. On November 15, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $25.50 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $19 on October 28, 2024. Macquarie initiated its recommendation with a Outperform and recommended $16 as its price target on September 25, 2024. Canaccord Genuity started tracking with a Buy rating for this stock on September 23, 2024, and assigned it a price target of $16. In a note dated September 04, 2024, Needham initiated an Buy rating and provided a target price of $16 on this stock.
Core Scientific Inc [CORZ] stock has fluctuated between $2.61 and $18.63 over the past year. Currently, Wall Street analysts expect the stock to reach $18.75 within the next 12 months. Core Scientific Inc [NASDAQ: CORZ] shares were valued at $9.31 at the most recent close of the market. An investor can expect a potential return of 101.4% based on the average CORZ price forecast.
Analyzing the CORZ fundamentals
Core Scientific Inc [NASDAQ:CORZ] reported sales of 510.67M for the trailing twelve months, which represents a drop of -33.12%. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -2.57%, and Net Profit Margin reading is -2.58%. To continue investigating profitability, this company’s Return on Assets is posted at -0.82, Equity is 1.78 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.92 points at the first support level, and at 8.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.57, and for the 2nd resistance point, it is at 9.84.
Ratios To Look Out For
For context, Core Scientific Inc’s Current Ratio is 6.72. Further, the Quick Ratio stands at 6.72, while the Cash Ratio is 6.21. Considering the valuation of this stock, the price to sales ratio is 5.36.
Transactions by insiders
Recent insider trading involved Weiss Eric Stanton, Director, that happened on Mar 06 ’25 when 6000.0 shares were purchased. Director, Levy Jordan completed a deal on Mar 06 ’25 to buy 62500.0 shares. Meanwhile, Director Becker Todd A sold 0.13 million shares on Mar 03 ’25.
